15 minutes delayed
Comments
Loading...
ALPN
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
(ALPN) Stock, Analyst Ratings, Price Targets, Forecasts
Quote.Descriptions.analyst-ratings.
Analyst Firms Making Recommendations1
Wedbush
Leerink Partners
RBC Capital
Morgan Stanley
Guggenheim
1calculated from analyst ratings
Analyst Ratings for
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/16/2024 | Buy Now | — | Wedbush | Robert Driscoll | → $65 | Reiterates | Neutral → Neutral | Get Alert |
| 04/16/2024 | Buy Now | — | TD Cowen | Boris Peaker | — | Downgrade | Buy → Hold | Get Alert |
| 04/12/2024 | Buy Now | — | Leerink Partners | Thomas Smith | $42 → $65 | Downgrade | Outperform → Market Perform | Get Alert |
| 04/11/2024 | Buy Now | — | RBC Capital | Gregory Renza | $41 → $65 | Downgrade | Outperform → Sector Perform | Get Alert |
| 04/11/2024 | Buy Now | — | Wedbush | Robert Driscoll | — | Downgrade | Outperform → Neutral | Get Alert |
| 04/11/2024 | Buy Now | — | Wolfe Research | Andy Chen | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 04/11/2024 | Buy Now | — | Morgan Stanley | Michael Ulz | $47 → $65 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/09/2024 | Buy Now | — | Guggenheim | Vamil Divan | → $55 | Initiates | → Buy | Get Alert |
| 03/21/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis | — | Maintains | Buy | Get Alert |
| 03/19/2024 | Buy Now | — | Wedbush | Robert Driscoll | → $47 | Reiterates | Outperform → Outperform | Get Alert |
| 03/19/2024 | Buy Now | — | Morgan Stanley | Michael Ulz | $30 → $47 | Maintains | Overweight | Get Alert |
| 03/19/2024 | Buy Now | — | Oppenheimer | Matthew Biegler | $33 → $44 | Reiterates | Outperform → Outperform | Get Alert |
| 03/19/2024 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis | $32 → $50 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | — | RBC Capital | Gregory Renza | $29 → $41 | Maintains | Outperform | Get Alert |
| 02/15/2024 | Buy Now | — | Wolfe Research | Andy Chen | — | Initiates | → Outperform | Get Alert |
| 01/26/2024 | Buy Now | — | Wedbush | Robert Driscoll | $26 → $35 | Maintains | Outperform | Get Alert |
| 12/22/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis | $17 → $32 | Maintains | Buy | Get Alert |
| 11/15/2023 | Buy Now | — | Wedbush | Robert Driscoll | → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 11/03/2023 | Buy Now | — | RBC Capital | Gregory Renza | $19 → $22 | Maintains | Outperform | Get Alert |
| 11/03/2023 | Buy Now | — | Wedbush | Robert Driscoll | $19 → $29 | Maintains | Outperform | Get Alert |
| 11/03/2023 | Buy Now | — | Morgan Stanley | Michael Ulz | $17 → $30 | Maintains | Overweight | Get Alert |
| 10/18/2023 | Buy Now | — | Berenberg | Andy Chen | → $18 | Initiates | → Buy | Get Alert |
| 10/05/2023 | Buy Now | — | RBC Capital | Gregory Renza | → $19 | Initiates | → Outperform | Get Alert |
| 09/13/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis | → $17 | Reiterates | Buy → Buy | Get Alert |
| 09/11/2023 | Buy Now | — | Oppenheimer | Mark Breidenbach | $14 → $22 | Maintains | Outperform | Get Alert |
| 09/01/2023 | Buy Now | — | Wedbush | Robert Driscoll | → $19 | Reiterates | Outperform → Outperform | Get Alert |
| 08/31/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis | → $17 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2023 | Buy Now | — | Wedbush | Robert Driscoll | $17 → $19 | Maintains | Outperform | Get Alert |
| 08/15/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis | $11 → $17 | Maintains | Buy | Get Alert |
| 06/26/2023 | Buy Now | — | Oppenheimer | Mark Breidenbach | → $14 | Assumes | → Outperform | Get Alert |
| 05/12/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis | → $11 | Reiterates | Buy → Buy | Get Alert |
| 03/24/2023 | Buy Now | — | Oppenheimer | Mark Breidenbach | → $14 | Reiterates | → Outperform | Get Alert |
| 01/19/2023 | Buy Now | — | Morgan Stanley | Michael Ulz | → $17 | Initiates | → Overweight | Get Alert |
| 11/21/2022 | Buy Now | — | SVB Leerink | Thomas Smith | → $16 | Initiates | → Outperform | Get Alert |
| 10/25/2022 | Buy Now | — | Oppenheimer | Mark Breidenbach | $17 → $14 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for (ALPN) stock?
The latest price target for (:ALPN) was reported by Wedbush on May 16, 2024. The analyst firm set a price target for $65.00 expecting ALPN to fall to within 12 months (a possible NaN% downside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for (ALPN)?
The latest analyst rating for (:ALPN) was provided by Wedbush, and reiterated their neutral rating.
When was the last upgrade for (ALPN)?
There is no last upgrade for
When was the last downgrade for (ALPN)?
The last downgrade for happened on April 16, 2024 when TD Cowen changed their price target from N/A to N/A for .
When is the next analyst rating going to be posted or updated for (ALPN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of , and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.
Is the Analyst Rating (ALPN) correct?
While ratings are subjective and will change, the latest (ALPN) rating was a reiterated with a price target of $0.00 to $65.00. The current price (ALPN) is trading at is $undefined, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.